Tissue and Cell, Год журнала: 2025, Номер unknown, С. 103005 - 103005
Опубликована: Июнь 1, 2025
Язык: Английский
Tissue and Cell, Год журнала: 2025, Номер unknown, С. 103005 - 103005
Опубликована: Июнь 1, 2025
Язык: Английский
Matter, Год журнала: 2025, Номер unknown, С. 102094 - 102094
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0Biomaterials, Год журнала: 2025, Номер unknown, С. 123324 - 123324
Опубликована: Апрель 1, 2025
The clinical application of human umbilical cord mesenchymal stem cells (hUCMSCs) in the treatment liver failure faces challenges due to cell quality, short engraftment time, and limited efficacy. Here, gelatin microcryogel (GM) microcarriers with pore sizes ranging from 15 36 μm were tuned mixed glutaraldehyde develop a 3D culture system hUCMSCs improved therapeutic effects. Bulk RNA sequencing vitro assays showed that 3D-hUCMSCs exhibited significant improvement signaling pathways related paracrine secretion anti-inflammation. These superior compared 2D-hUCMSCs not only terms secretion, protection oxidation, resistance mechanical force damage, but also had better function effect than when they transplanted as single into injury mice. Furthermore, sponge patch grafting (GSPG) strategy was developed enable direct within GM microcarriers. results overall host significantly improved, life span hosts extended. Our study provided practical achieve high long retraining time rescuing acute matrixes.
Язык: Английский
Процитировано
0Tissue and Cell, Год журнала: 2025, Номер unknown, С. 103005 - 103005
Опубликована: Июнь 1, 2025
Язык: Английский
Процитировано
0